A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects
Clinical trial NCT01762878 · COMPLETED
Trial details
- NCT number
- NCT01762878
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-09
- Primary completion
- 2013-10-21
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.